Primary |
Chronic Obstructive Pulmonary Disease |
74.1% |
Hypertension |
6.8% |
Asthma |
3.6% |
Pain |
1.6% |
Coronary Artery Disease |
1.4% |
Cardiac Failure |
1.3% |
Atrial Fibrillation |
1.1% |
Condition Aggravated |
1.1% |
Diabetes Mellitus |
1.1% |
Bronchitis Chronic |
0.9% |
Dyslipidaemia |
0.9% |
Hypercholesterolaemia |
0.9% |
Prophylaxis |
0.9% |
Arterial Occlusive Disease |
0.7% |
Carotid Artery Stenosis |
0.7% |
Depression |
0.7% |
Vitamin Supplementation |
0.7% |
Aortic Valve Stenosis |
0.5% |
Bronchiectasis |
0.5% |
Gastritis |
0.5% |
|
Weight Decreased |
19.9% |
Pneumonia |
13.8% |
Death |
11.6% |
Dyspnoea |
6.1% |
Nausea |
5.5% |
Tremor |
5.5% |
Medication Error |
5.0% |
Diarrhoea |
3.9% |
Unevaluable Event |
3.9% |
Vomiting |
3.9% |
Chronic Obstructive Pulmonary Disease |
3.3% |
Decreased Appetite |
2.8% |
Wrong Technique In Drug Usage Process |
2.8% |
Respiratory Failure |
2.2% |
Condition Aggravated |
1.7% |
Dizziness |
1.7% |
Hepatic Cirrhosis |
1.7% |
Lung Infection |
1.7% |
Malaise |
1.7% |
Musculoskeletal Stiffness |
1.7% |
|
Secondary |
Chronic Obstructive Pulmonary Disease |
72.6% |
Hypertension |
8.0% |
Dysuria |
3.2% |
Bronchitis Chronic |
1.6% |
Dyslipidaemia |
1.6% |
Cardiac Failure |
1.3% |
Coronary Artery Disease |
1.3% |
Pain |
1.3% |
Asthma |
1.0% |
Blood Cholesterol Increased |
1.0% |
Bronchitis |
1.0% |
Diabetes Mellitus |
1.0% |
Lung Infection |
1.0% |
Medical Diet |
1.0% |
Skin Infection |
1.0% |
Anaemia |
0.6% |
Gout |
0.6% |
Nephrolithiasis |
0.6% |
Anxiety |
0.3% |
Aortic Valve Disease |
0.3% |
|
Weight Decreased |
22.0% |
Nausea |
16.5% |
Pneumonia |
8.8% |
Medication Error |
6.6% |
Tachycardia |
6.6% |
Wrong Technique In Drug Usage Process |
6.6% |
Chronic Obstructive Pulmonary Disease |
5.5% |
Liver Injury |
4.4% |
Deafness Neurosensory |
3.3% |
Diarrhoea |
2.2% |
Drug Ineffective |
2.2% |
Dyspnoea |
2.2% |
Hypoglycaemia |
2.2% |
Muscular Weakness |
2.2% |
Palpitations |
2.2% |
Restlessness |
2.2% |
Abnormal Loss Of Weight |
1.1% |
Back Pain |
1.1% |
Breast Pain |
1.1% |
Cardiac Arrest |
1.1% |
|
Concomitant |
Product Used For Unknown Indication |
20.4% |
Asthma |
11.8% |
Chronic Obstructive Pulmonary Disease |
10.0% |
Cardiac Failure Congestive |
8.3% |
Hypertension |
7.3% |
Neuropathy Peripheral |
6.9% |
Back Pain |
5.5% |
Osteoporosis |
4.2% |
Seasonal Allergy |
3.1% |
Depression |
2.8% |
Urinary Retention |
2.8% |
Drug Use For Unknown Indication |
2.4% |
Hypotension |
2.4% |
Anxiety |
2.1% |
Hypothyroidism |
2.1% |
Ventricular Fibrillation |
2.1% |
Pruritus |
1.7% |
Cardiovascular Event Prophylaxis |
1.4% |
Dyslipidaemia |
1.4% |
Insomnia |
1.4% |
|
Dyspnoea |
10.3% |
Overdose |
7.7% |
Pneumonia |
7.7% |
Wheezing |
7.7% |
Cardiac Failure Chronic |
5.1% |
Cholestasis |
5.1% |
Chronic Obstructive Pulmonary Disease |
5.1% |
Headache |
5.1% |
Malaise |
5.1% |
No Adverse Event |
5.1% |
Pulmonary Mass |
5.1% |
Subileus |
5.1% |
Treatment Noncompliance |
5.1% |
Visual Impairment |
5.1% |
Abdominal Pain Upper |
2.6% |
Anxiety |
2.6% |
Asthenia |
2.6% |
Atrial Fibrillation |
2.6% |
Blood Pressure Decreased |
2.6% |
Blood Test Abnormal |
2.6% |
|